Study of histopathology of tumors of the central nervous system in a teaching hospital

Authors

DOI:

https://doi.org/10.15587/2519-4798.2022.265313

Keywords:

gliomas, astrocytoma, schwannomas, diagnostic accuracy, immunohistochemistry, antibodies, central nervous system, malignant tumours, computerised tomography, magnetic resonance imaging (MRI)

Abstract

Primary central nervous system (CNS) tumours are rare, but they are the second most common in childhood after the most common malignancy, leukaemia. They are considered the most notorious of all cancers. They represent characteristics of a unique, heterogeneous population of neoplasms with benign and malignant tumours and are reported to be less than 2 % of all malignant neoplasms.

The aim of the study: To study various tumours of the central nervous system (CNS)

Methods: A prospective study on CNS tumours was conducted in the department of Pathology, Guntur Medical College, Guntur, for two years, from June 2011 to May 2013. The data necessary for the study has been retrieved from the histopathology records at the department. 104 cases of CNS tumours were studied in detail, correlating the clinical, radiological and histopathological findings. The department of neurosurgery has provided the biopsy material. The applied nomenclature is that adopted by the 2007 WHO classification.

Results: The tumours have been encountered in all age groups, from infants to 80yr elderly persons. The highest frequency is seen in the age group of 41 to 50 years (27 %), followed by 51 to 60 years age group (19 %). The most common tumour reported was astrocytomas constituting 21.1 % (22/104), followed by schwannomas constituting 19.2 % (20/104). least reported was plasmacytoma astrobalstoma 0.9 % (1/104).

Conclusion: Adequate imaging by CT/MRI is an essential aid in the diagnosis. Although H&E staining is the mainstay for histopathological diagnosis, immunohistochemistry has played a significant role in diagnostic accuracy. In addition, the judicious use of a panel of selected antibodies is helpful in diagnostically challenging cases

Author Biographies

Katakonda Sunitha, Mamata Academy of Medical Sciences

Assistant Professor

Department of Pathology

Mulukutla Partha Akarsh, Government medical college

Assistant Professor

 Department of Pathology

Geetha Vani Panchakarla, Guntur Medical College

Assistant Professor

Department of Pathology

References

  1. Ostrom, Q. T., Patil, N., Cioffi, G., Waite, K., Kruchko, C., Barnholtz-Sloan, J. S. (2020). CBTRUS Statistical Report: Primary Brain and Other Central Nervous System Tumors Diagnosed in the United States in 2013–2017. Neuro-Oncology, 22 (1), iv1–iv96. doi: https://doi.org/10.1093/neuonc/noaa200
  2. Vovoras, D., Pokhrel, K. P., Tsokos, C. P. (2014). Epidemiology of Tumors of the Brain and Central Nervous System: Review of Incidence and Patterns among Histological Subtypes. Open Journal of Epidemiology, 4 (4), 224–234. doi: https://doi.org/10.4236/ojepi.2014.44029
  3. E. G. Ordóñez-Rubiano, S. Rodríguez-Vargas, J. Ospina-Osorio, J. G. Patiño, Sánchez-Rueda, D. M., Zorro-Guío, O. F. (2018). Stereotactic frame-based guided brain biopsies: experience in a center at Latin America. Revista Chilena de Neurocirugía, 44, 140–144.
  4. Osborn, A. G., Louis, D. N., Poussaint, T. Y., Linscott, L. L., Salzman, K. L. (2022). The 2021 World Health Organization Classification of Tumors of the Central Nervous System: What Neuroradiologists Need to Know. American Journal of Neuroradiology, 43 (7), 928–937. doi: http://doi.org/10.3174/ajnr.a7462
  5. Duffau, H. (2018). Paradoxes of evidence-based medicine in lower-grade glioma. Neurology, 91 (14), 657–662. doi: http://doi.org/10.1212/wnl.0000000000006288
  6. Nelson, S., Taylor, L. P. (2014). Headaches in Brain Tumor Patients: Primary or Secondary? Headache: The Journal of Head and Face Pain, 54 (4), 776–785. doi: https://doi.org/10.1111/head.12326
  7. Ravi, D., Vara Prasad, K., Pallikonda, V., Raman, B. S. (2017). Clinicopathological study of pediatric posterior fossa tumors. Journal of Pediatric Neurosciences, 12 (3), 245–250. doi: https://doi.org/10.4103/jpn.jpn_113_16
  8. Ardhini, R., Tugasworo, D. (2019). Epidemiology of primary brain tumors in dr. Kariadi Hospital Semarang in 2015–2018. E3S Web of Conferences, 125, 16004. doi: https://doi.org/10.1051/e3sconf/201912516004
  9. Kanthikar, S. N., Nikumbh, D. B., Dravid, N. V. (2017). Histopathological overview of central nervous system tumours in North Maharashtra, India: a single center study. Journal of Pathology and Oncology, 4 (1), 80–84.
  10. Ostrom, Q. T., Cioffi, G., Gittleman, H., Patil, N., Waite, K., Kruchko, C., Barnholtz-Sloan, J. S. (2019). CBTRUS Statistical Report: Primary Brain and Other Central Nervous System Tumors Diagnosed in the United States in 2012–2016. Neuro-Oncology, 21 (5), v1–v100. doi: https://doi.org/10.1093/neuonc/noz150
  11. CBTRUS Statistical Report: Primary brain and CNS tumors diagnosed in the US in 2004–2007 (2011). Child Astrocytoma Treatment (PDQ)- Health professional Version-National Cancer Institute.
  12. Dho, Y.-S., Jung, K.-W., Ha, J., Seo, Y., Park, C.-K., Won, Y.-J., Yoo, H. (2017). An Updated Nationwide Epidemiology of Primary Brain Tumors in Republic of Korea, 2013. Brain Tumor Research and Treatment, 5 (1), 16–23. doi: https://doi.org/10.14791/btrt.2017.5.1.16
  13. Louis, D. N., Perry, A., Reifenberger, G., von Deimling, A., Figarella-Branger, D. et. al. (2016). The 2016 World Health Organization Classification of Tumors of the Central Nervous System: a summary. Acta Neuropathologica, 131 (6), 803–820. doi: https://doi.org/10.1007/s00401-016-1545-1
  14. Goutagny, S., Bah, A. B., Henin, D., Parfait, B., Grayeli, A. B., Sterkers, O., Kalamarides, M. (2012). Long-term follow-up of 287 meningiomas in neurofibromatosis type 2 patients: clinical, radiological, and molecular features. Neuro-Oncology, 14 (8), 1090–1096. doi: https://doi.org/10.1093/neuonc/nos129
  15. Usubalieva, A., Pierson, C. R., Kavran, C. A., Huntoon, K., Kryvenko, O. N., Mayer, T. G. et. al. (2015). Primary Meningeal Pleomorphic Xanthoastrocytoma With Anaplastic Features: A Report of 2 Cases, One WithBRAFV600EMutation and Clinical Response to theBRAFInhibitor Dabrafenib. Journal of Neuropathology & Experimental Neurology, 74 (10), 960–969. doi: https://doi.org/10.1097/nen.0000000000000240
  16. Wu, J., Armstrong, T. S., Gilbert, M. R. (2016). Biology and management of ependymomas. Neuro-Oncology, 18 (7), 902–913. doi: https://doi.org/10.1093/neuonc/now016
  17. Bellizzi, A. M. (2020). An Algorithmic Immunohistochemical Approach to Define Tumor Type and Assign Site of Origin. Advances in Anatomic Pathology, 27 (3), 114–163. doi: https://doi.org/10.1097/pap.0000000000000256
  18. Varma, A. V., Gupta, G., Gupta, J., Gupta, S. (2018). Gfap expression in neuroglial tumours- immunohistochemical confirmation for diagnosis and grading. Journal of Evolution of Medical and Dental Sciences, 7 (46), 5034–5038. doi: https://doi.org/10.14260/jemds/2018/1120
  19. Kurdi, M., Eberhart, C. (2021). Immunohistochemical expression of Olig2, CD99, and EMA to differentiate oligodendroglial-like neoplasms. Folia Neuropathologica, 59 (3), 284–290. doi: https://doi.org/10.5114/fn.2021.108526
  20. Walke, V., Sisodia, S., Bijwe, S., Patil, P. (2014). Clear-cell meningioma: Intraoperative diagnosis by squash cytology: Case report and review of the literature. Asian Journal of Neurosurgery, 12 (2), 293–295. doi: https://doi.org/10.4103/1793-5482.146392

Downloads

Published

2022-09-30

How to Cite

Sunitha, K., Akarsh, M. P., & Panchakarla, G. V. (2022). Study of histopathology of tumors of the central nervous system in a teaching hospital. ScienceRise: Medical Science, (5 (50), 24–31. https://doi.org/10.15587/2519-4798.2022.265313

Issue

No. 5 (50) (2022)

Section

Medical Science

License

Copyright (c) 2022 Katakonda Sunitha, Mulukutla Partha Akarsh, Geetha Vani Panchakarla

Creative Commons License

This work is licensed under a Creative Commons Attribution 4.0 International License.

Our journal abides by the Creative Commons CC BY copyright rights and permissions for open access journals.

Authors, who are published in this journal, agree to the following conditions:

1. The authors reserve the right to authorship of the work and pass the first publication right of this work to the journal under the terms of a Creative Commons CC BY, which allows others to freely distribute the published research with the obligatory reference to the authors of the original work and the first publication of the work in this journal.

 2. The authors have the right to conclude separate supplement agreements that relate to non-exclusive work distribution in the form in which it has been published by the journal (for example, to upload the work to the online storage of the journal or publish it as part of a monograph), provided that the reference to the first publication of the work in this journal is included.